Intense competition foreseeable in domestic antipsychotic market

The local antipsychotic market will become fierce, as the future outlook for AstraZeneca’s Seroquel (quetiapine fumarate) is expected to be cloudy by numerous generic drug manufacturers including Whanin Pharm, who launched its generic Seroquel 25mg and 200mg.

Although the antipsychotic market has up until now had relatively low exposure to generics, the future entrance of generic quetiapine ...